XBI

SPDR S&P BIOTECH ETF
A

50
  • Overview
  • Efficiency
  • Tradability
  • Fit

XBI Fund Description

The SPDR S&P Biotech ETF tracks an equal-weighted index of US biotechnology stocks.

XBI Factset Analytics Insight

XBI provides exposure to one of the broadest portfolios among US biotech ETFs. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with relatively small pharma overlap as we see it. This highly efficient fund, which charges less than competing funds, has a history of beating its index due to revenue from securities lending. It has attracted a large asset base and trades with excellent volume. The fund’s alternative take on the space earns it a place on our Opportunities List.

XBI MSCI ESG Analytics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of November 21, 2017 the SPDR S&P BIOTECH ETF MSCI ESG Fund Quality Score is 4.13 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. XBI ranks in the 6th percentile within its peer group and in the 11st percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:

XBI Top 10 Countries

XBI Top 10 Sectors

XBI Top 10 Holdings View All

XBI Summary Data

SPDR
01/31/06
Open-Ended Fund
0.35%
$4.13B
$308.99M
0.04%

XBI Portfolio Data

$16.36B
-20.24
6.76
0.23%
12/15/17
102

XBI Index Data

Equal
Market Cap
Thomson Reuters US Biotechnology & Medical Research

Related ETFs to XBI

FBT, BBP, CNCR, BBC
Total Return
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max

XBI Portfolio Management

0.35%
-0.07%
0.22%
-0.2%

XBI Tax Exposures

20% / 39.6%
--
Qualified dividends
No

XBI Fund Structure

Open-Ended Fund
No
Yes
100% / 0%
N/A
N/A
Low
Daily
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
13:34:5781.98100
13:26:1581.98100
13:15:0681.98100
13:09:1182.08100
13:06:1181.97100
13:04:5282.07100
13:01:5082.07100
12:59:5982.00100
12:59:5882.00800
12:59:5882.01100
Bats BZX Real-time Quote - 23:59:59
Daily Spread
Premium/Discount
Volume

XBI Factset Analytics Block Liquidity

As of 11/22/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of XBI. XBI is rated a 5 out of 5.

XBI Tradability

3,670,983
$308.99M
3,452,907
$291.71M
0.04%
$0.03
0%
0.17% / -0.2%
None
100%
50,000
69.06
0.01%
0.14%
392,379
$81.34
5

XBI Geographic Exposure

XBISegment Benchmark
99.48% 100.00%
0.52% --

XBISegment Benchmark
99.48% 100.00%
0.52% --
99.48% / 0.52% 100.00% / 0.00%

XBI Performance Statistics

0.8
1.31
1.18
1.34
0.67%
Thomson Reuters US Biotechnology & Medical Research

XBI MSCI ESG Ratings

4.13 / 10
6.4
10.89
1.37%
16.41%
23.97

XBI BENCHMARK COMPARISON

    XBI
    102 Holdings
    Segment Benchmark
    125 Constituents
    Shared Holdings
    86 (Count)
     
    43.94% (Weight)
XBISegment Benchmark
52.32% 17.89%
29.63% 43.99%
16.09% 35.60%
1.95% 2.53%
146.49 -20.24
0.67% 0.14%
High Low